Whole‐exome sequencing‐based mutational profiling of hepatocellular adenoma malignant transformation to hepatocellular carcinoma

Yichao Bu, Zheng Tang(Ministry of Education of the People's Republic of China), Xiutao Fu(Fudan University), Diyu Chen(Blood Center of Zhejiang Province), Xin Wang(Jiangsu University), Jia Fan(Nanjing Tech University), Zhen‐Bin Ding(Fudan University), Weiren Liu(Fudan University), Run Huang(Ministry of Education of the People's Republic of China), Jun Gao(Ministry of Education of the People's Republic of China), Jian Zhou(Ministry of Education of the People's Republic of China), Wei‐Feng Qu(Ministry of Education of the People's Republic of China)
Clinical and Experimental Pharmacology and Physiology
June 6, 2024
10.1111/1440-1681.13901
Cited by 3

Related Papers

Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
|Cell|2019|1.2k
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
|Nature Metabolism|2023|540
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436